Home NF-κB NF-κB inhibitor Withaferin A (WFA) For research use only.

Withaferin A (WFA)

Synonyms: WA

Withaferin A (WFA) potently inhibits NF-κB activation by preventing the tumor necrosis factor-induced activation of IκB kinase β via a thioalkylation-sensitive redox mechanism. Withaferin A binds to the intermediate filament (IF) protein, vimentin with antitumor and antiangiogenesis activity. Withaferin A is a steroidal lactone isolated from Withania somnifera.

Withaferin A (WFA) Chemical Structure

Withaferin A (WFA) Chemical Structure

CAS: 5119-48-2

Selleck's Withaferin A (WFA) has been cited by 10 publications

Purity & Quality Control

Batch: Purity: 99.92%
99.92

Withaferin A (WFA) Related Products

Signaling Pathway

NF-κB Signaling Pathways

NF-κB Signaling Pathway

Choose Selective NF-κB Inhibitors

Biological Activity

Description Withaferin A (WFA) potently inhibits NF-κB activation by preventing the tumor necrosis factor-induced activation of IκB kinase β via a thioalkylation-sensitive redox mechanism. Withaferin A binds to the intermediate filament (IF) protein, vimentin with antitumor and antiangiogenesis activity. Withaferin A is a steroidal lactone isolated from Withania somnifera.
Targets
NF-κB [1] vimentin [2]
In vitro
In vitro

Withaferin A potently inhibits NFκB activation by preventing the tumor necrosis factor-induced activation of IκB kinase β via a thioalkylation-sensitive redox mechanism.[1] Withaferin A binds to the intermediate filament (IF) protein, vimentin, by covalently modifying its cysteine residue, which is present in the highly conserved α-helical coiled coil 2B domain. Withaferin A induces vimentin filaments to aggregate in vitro.[2]
Cell Research Cell lines HUVECs, BAECs,MCF-7 breast cancer cell line, MFT-16 cells
Concentrations 5 μM, 10 μM
Incubation Time 1 h, 2 h, 24 h
Method

To assess the apoptosis activity of WFA and 12-D WS, embryonic fibroblast vimentindeficient cell lines (Vim−/−; MFT-16) and wild-type (Vim+/+; MFT-6) cells are treated with 5 μM WFA, 5 μM 12-D WS, or an equivalent amount of vehicle (DMSO) for 24 hr in 37℃-5% CO2 conditions in complete medium. Apoptotic cells are measured with the Vybrant Apoptosis Assay Kit according to the manufacturer's instructions.
In Vivo
In vivo

Withagerin A clearly displays anti-inflammatory characteristics in an acute inflammatory mouse model.[1] Withagerin A-induced inhibition of capillary growth in a mouse model of corneal neovascularization is compromised in vimentin-deficient mice.[2]
Animal Research Animal Models 8-week-old C57BL/6J mice
Dosages 0.5 mg/mouse
Administration IP
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT01199250 Not yet recruiting
Lynch Syndrome|Recurrent Uterine Corpus Carcinoma|Stage I Uterine Corpus Cancer|Stage II Uterine Corpus Cancer|Stage III Uterine Corpus Cancer|Stage IV Uterine Corpus Cancer
Gynecologic Oncology Group|National Cancer Institute (NCI)|GOG Foundation
 January 2100 --
NCT04432610 Withdrawn
Bisoprolol Adverse Reaction|Nebivolol Adverse Reaction
Clinical Hospital Center Zemun
 January 2030 Phase 4
NCT05986214 Not yet recruiting
Chronic Obstructive Pulmonary Disease
VA Office of Research and Development
 March 1 2026 Not Applicable
NCT05536739 Not yet recruiting
Stroke
Georgia Institute of Technology|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
 January 1 2026 Not Applicable
NCT04300764 Not yet recruiting
Coronary Artery Disease|Coronary Heart Disease|Hypertension|Diabete Mellitus|Dyslipidemias|Obesity|Heart Failure
University of Pennsylvania
 January 1 2026 Not Applicable

Chemical Information & Solubility

Molecular Weight 470.60 Formula

C28H38O6
CAS No. 5119-48-2 SDF --
Storage (From the date of receipt) 3 years -20°C powder

In vitro
Batch:

DMSO : 94 mg/mL ( (199.74 mM)； Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 4 mg/mL

Water : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Withaferin A (WFA) | Withaferin A (WFA) supplier | purchase Withaferin A (WFA) | Withaferin A (WFA) cost | Withaferin A (WFA) manufacturer | order Withaferin A (WFA) | Withaferin A (WFA) distributor